Results 121 to 130 of about 11,948 (164)

Preventing graft re-JAK-tion: safer transplant conditioning enables murine islet allograft tolerance and diabetes reversal. [PDF]

J Clin Invest
Persaud SP, DiPersio JF.
europepmc   +1 more source

Cutaneous Lymphoma Associated with JAK Inhibitors: A Pharmacovigilance Analysis of the FAERS Database and Literature Review. [PDF]

Acta Derm Venereol
Lu L, Feng J, He H, Peng Y, Zhang S, Yang L, Liu Y, Wang T.   +7 more
europepmc   +1 more source

Efficacy and Safety of Small Molecule Inhibitor Therapies for Vitiligo: A Systematic Review. [PDF]

Health Sci Rep
Jafarzadeh A, Darvishi MA, Khosravi M, Roohaninasab M, Goodarzi A.   +4 more
europepmc   +1 more source

Janus Kinase Inhibitor Discontinuation at a UK Tertiary Centre: A Retrospective Study. [PDF]

Cureus
Bland K, Jubber A, Ganguly S, Moorthy A.
europepmc   +1 more source

The cost-effectiveness of using vilobelimab with immunomodulators to treat severely ill mechanically ventilated patients with COVID-19: A subgroup analysis of the PANAMO study. [PDF]

Am J Health Syst Pharm
Malone DC, Seheult R, Brixner D, Oderda G, Burnett BP, Biskupiak J.   +5 more
europepmc   +1 more source

Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review. [PDF]

Front Immunol
Wan Z, Wang Y, Yang D.
europepmc   +1 more source

The effect of baricitinib on pSTAT3 levels in IL-6- or IL-15-stimulated PBMCs isolated from patients with SLE. [PDF]

Front Immunol
Szebeni GJ, Gémes N, Neuperger P, Szabó E, Balog JÁ, Honfi D, Balog A, Toldi G.   +7 more
europepmc   +1 more source

Comparison of tofacitinib, baricitinib, upadacitinib and filgotinib: a 2-year observational study from FIRST registry. [PDF]

RMD Open
Sonomoto K, Nakayamada S, Sakai H, Ueno M, Tanaka H, Nagayasu A, Aritomi T, Okawara M, Nakata A, Tanaka Y.   +9 more
europepmc   +1 more source

Understanding Cardiovascular Events With JAK Inhibitors: Similarities and Differences of the Vascular Effects Between Different JAK Inhibitors on Endothelial Cells Exposed to Inflammatory Cytokines. [PDF]

ACR Open Rheumatol
Zavoriti A, Miossec P.
europepmc   +1 more source

Correction to: Bone Mineral Density During Treatment with The Janus Kinase Inhibitor Baricitinib in Patients with Rheumatoid Arthritis: A Monocentric Observational Study. [PDF]

Calcif Tissue Int
Schulz N, Asendorf T, van Wijnen P, Wilhelmi T, Müller-Ladner U, Lange U, Klemm P.   +6 more
europepmc   +1 more source